SCA
BIIB icon

Snowden Capital Advisors’s Biogen BIIB Stock Holding History

Snowden Capital Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,307
Closed -$303K – 1220
2024
Q2 		$303K Buy
1,307
+106
+9% +$23K 0.01% 967
2024
Q1 		$259K Buy
1,201
+61
+5% +$14.3K 0.01% 1023
2023
Q4 		$295K Sell
1,140
-27
-2% -$6.63K 0.01% 915
2023
Q3 		$300K Sell
1,167
-424
-27% -$113K 0.01% 858
2023
Q2 		$453K Buy
1,591
+39
+3% +$11.6K 0.02% 779
2023
Q1 		$432K Buy
1,552
+71
+5% +$19.6K 0.02% 790
2022
Q4 		$410K Buy
1,481
+437
+42% +$123K 0.02% 796
2022
Q3 		$278K Sell
1,044
-63
-6% -$13.4K 0.01% 918
2022
Q2 		$225K Buy
+1,107
New +$226K 0.01% 992
2022
Q1 		– Sell
-390
Closed -$93K – 1157
2021
Q4 		$93K Buy
+390
New +$100K ﹤0.01% 863
2021
Q3 		– Sell
-623
Closed -$216K – 870
2021
Q2 		$216K Sell
623
-122
-16% -$37K 0.01% 818
2021
Q1 		$208K Sell
745
-1,810
-71% -$488K 0.01% 751
2020
Q4 		$626K Buy
+2,555
New +$659K 0.04% 389
2019
Q1 		– Sell
-1,194
Closed -$359K – 493
2018
Q4 		$359K Sell
1,194
-22
-2% -$7.02K 0.05% 350
2018
Q3 		$430K Buy
+1,216
New +$419K 0.05% 338

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Snowden Capital Advisors's BIIB Position: Q3 2024 in Review

Snowden Capital Advisors sold out of Biogen (BIIB) in Q3 2024, closing a stake of 1,307 shares — an estimated $303K sold.

Snowden Capital Advisors first reported a position in BIIB in Q3 2018 and held it in 15 quarters. The position peaked at $626K in Q4 2020. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Snowden Capital Advisors reported no remaining Biogen position as of Q3 2024 after selling out during the quarter.
  • Snowden Capital Advisors sold 1,307 Biogen shares in Q3 2024, an estimated $303K.
  • Snowden Capital Advisors first reported a position in Biogen in Q3 2018 and held it in 15 quarters.
  • Snowden Capital Advisors's Biogen position peaked at $626K in Q4 2020.
  • 917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Snowden Capital Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.